GlassScriptPhysician profile
Conway Ella
NPI 1487607537
$3,975.22
in general payments reported to CMS, 2019-2025
22 companies · $529 in 2025
The $529 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $798 · 2022: $889 · 2023: $903 · 2024: $856 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,670.06 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $405.82 | 2021-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $315.99 | 2021-2025 | Entyvio, Eohilia, Gattex |
| Pacira Pharmaceuticals Incorporated | $246.09 | 2022 | |
| Merck Sharp & Dohme LLC | $231.94 | 2021-2024 | Dificid |
| Aimmune Therapeutics, INC. | $134.25 | 2024-2025 | Zenpep |
| Qol Medical, LLC | $124.27 | 2021-2024 | Sucraid, Sucraid |
| Heron Therapeutics, INC. | $121.83 | 2024 | Aponvie |
| Spinefrontier, INC. | $120.51 | 2024-2025 | Sijfuse, Inspan, Nanofuse |
| Nestle Healthcare Nutrition INC. | $108.03 | 2022-2023 | |
| Inspire Medical Systems, INC. | $85.44 | 2024 | Inspire |
| Redhill Biopharma INC. | $76.83 | 2021-2024 | Talicia |
| Octapharma USA, INC. | $59.57 | 2025 | Fibryga |
| Phathom Pharmaceuticals, INC. | $53.11 | 2024 | Voquezna |
| Celltrion USA INC. | $40.41 | 2025 | Vegzelma |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $38.72 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $33.96 | 2024-2025 | Omvoh |
| Medtronic, INC. | $28.14 | 2021-2025 | Inceptiv |
| Braintree Laboratories, INC. | $22.42 | 2022 | |
| Nalu Medical, INC. | $22.17 | 2024 | Nalu Neurostimulation System |
| Ardelyx, INC. | $19.71 | 2025 | Ibsrela |
| Saluda Medical Americas, INC. | $15.95 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conway Ella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.